Nanoviricides, inc. (NNVC)
Income statement / Yearly
Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10
OPERATING EXPENSES
Research and development

5,921

5,913

6,565

5,028

3,660

5,131

4,292

4,265

4,155

3,367

Refund credit research and development costs

-

-

-

-

-

-

-

0

0

-162

General and administrative

2,737

3,411

3,034

3,830

3,402

3,535

2,297

1,815

2,273

1,735

Total operating expenses

8,659

9,325

9,600

8,859

7,063

8,667

6,590

6,081

6,429

4,939

LOSS FROM OPERATIONS

-8,659

-9,325

-9,600

-8,859

-7,063

-8,667

-6,590

-6,081

-6,429

-4,939

OTHER INCOME (EXPENSE):
Interest income

55

100

60

62

160

171

-

-

-

-

Interest expense on convertible debentures

0

185

780

1,042

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

55

46

14

2

Interest expense

-

-

-

-

2,649

3,092

962

0

0

-

Loss on extinguishment of debt

0

-1,348

-332

0

0

-

-

-

-

-

Discount on convertible debentures

0

359

1,347

1,427

1,175

569

129

0

0

0

Beneficial conversion feature of convertible debentures

-

-

-

-

-

-

-

0

0

0

Change in fair value of derivative

179

2,554

1,696

541

8,529

-1,443

-1,249

-172

-62

192

Other (expense) income

235

761

-703

-1,865

4,864

-4,934

-2,285

-125

-47

195

LOSS BEFORE INCOME TAX PROVISION

-8,424

-8,563

-10,304

-10,724

-2,198

-13,601

-8,875

-6,207

-6,477

-4,744

INCOME TAX PROVISION

0

0

0

0

0

0

0

0

0

0

NET LOSS

-8,424

-8,563

-10,304

-10,724

-2,198

-13,601

-8,875

-6,207

-6,477

-4,744

NET LOSS PER COMMON SHARE
- Basic

-

-

-

57,669

56,553

51,225

45,892

-

-

-

- Diluted

-

-

-

57,669

59,220

51,225

47,606

-

-

-

Net loss per common share- basic and diluted

-0.12

-0.13

-0.17

-

-

-

-

-0.15

-0.16

-0.04

- Basic

-

-

-

-0.19

-0.04

-0.27

-0.19

-

-

-

- Diluted

-

-

-

-0.19

-0.09

-0.27

-0.19

-

-

-

Weighted average common shares outstanding
Weighted average common shares outstanding- basic and diluted

71,801

64,920

60,102

-

-

-

-

42,763

39,765

130,497